These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 10414145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Value of tumor markers in surveillance of primary bronchial cancers and to evaluate therapy].
    Sculier JP.
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S23-6. PubMed ID: 9229744
    [No Abstract] [Full Text] [Related]

  • 4. Clinical utility of tissue polypeptide antigen determination in lung cancer management.
    Rapellino M, Pecchio F, Baldi S, Scappaticci E, Cavallo A.
    Anticancer Res; 1995 Apr; 15(3):1065-70. PubMed ID: 7645927
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predicaments in and prospects for lung cancer.
    Lillington GA.
    Curr Opin Pulm Med; 1996 Jul; 2(4):261-2. PubMed ID: 9363149
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Bronchial carcinoma: how far should the diagnosis go?].
    Macha HN.
    Pneumologie; 1991 Jun; 45(6):508-10. PubMed ID: 1924226
    [No Abstract] [Full Text] [Related]

  • 9. Amylase in bronchial washings as an aid to early diagnosis of bronchogenic carcinoma.
    Rao S.
    J Assoc Physicians India; 1995 Jun; 43(6):400. PubMed ID: 8906945
    [No Abstract] [Full Text] [Related]

  • 10. Selecting appropriate therapy for bronchial carcinoma.
    Shields TW.
    Geriatrics; 1974 Jul; 29(7):54-60. PubMed ID: 4835739
    [No Abstract] [Full Text] [Related]

  • 11. [Which tumor markers should be used in primary bronchial cancers?].
    Schuller MP, Carrat F, Urban T, Lebeau B.
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S9-14. PubMed ID: 9229750
    [No Abstract] [Full Text] [Related]

  • 12. [The significance of tumor-associated antigens in the diagnosis and therapeutic control of bronchial cancer].
    Gropp C, Luster W, Havemann K.
    Prax Klin Pneumol; 1982 Dec; 36(12):491-9. PubMed ID: 7163127
    [No Abstract] [Full Text] [Related]

  • 13. [Parotid metastasis disclosing bronchial carcinoma].
    Guichenez P, Chaussinand JP, Prades JM, Jourdan M, Pesquie E.
    Rev Pneumol Clin; 1993 Dec; 49(4):197. PubMed ID: 8296154
    [No Abstract] [Full Text] [Related]

  • 14. [Approach to the patient with bronchial cancer by the practicing physician].
    Sculier JP, Klastersky J.
    Rev Med Brux; 1986 Oct; 7(8):473-9. PubMed ID: 3541102
    [No Abstract] [Full Text] [Related]

  • 15. [Bronchial carcinoma: does the solution come with individualized therapy?].
    Fath R.
    Dtsch Med Wochenschr; 2005 Oct 28; Suppl 1():16-7. PubMed ID: 16379229
    [No Abstract] [Full Text] [Related]

  • 16. [Bronchial carcinoma--a challenge for pneumology].
    Pneumologie; 1990 Aug 28; 44(8):923-4. PubMed ID: 2217087
    [No Abstract] [Full Text] [Related]

  • 17. [Recent advances in bronchogenic carcinoma. V. Diagnosis and multimodal medical treatment].
    García-Sáinz M.
    Gac Med Mex; 1991 Aug 28; 127(1):58-63. PubMed ID: 1959744
    [No Abstract] [Full Text] [Related]

  • 18. [Bronchial carcinoma: news from diagnostics and therapy].
    Puderbach M, Delorme S.
    Radiologe; 2010 Aug 28; 50(8):653. PubMed ID: 20628722
    [No Abstract] [Full Text] [Related]

  • 19. [Early diagnosis of bronchial carcinoma].
    Neumann G.
    Pneumologie; 1990 Aug 28; 44(8):925-42. PubMed ID: 2217088
    [No Abstract] [Full Text] [Related]

  • 20. [Re-evaluation of bronchogenic carcinoma after radiochemotherapy. Role of CT and MR].
    Gualdi GF, Minerva RE, Volpe A, Polettini E, Anaveri G.
    Clin Ter; 1994 Oct 28; 145(10):313-7. PubMed ID: 7820989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.